Evaluation of Stem Cell Therapy as Potential Treatment for COVID-19 Pneumonia
Clinical Trial showing preliminary evidence of mesenchymal stem cell (MSC) therapy for COVID-19 pneumonia patients used biotechnology tools from Fluidigm Corporation. Innovative biotechnology tools...